Cryofocus Medtech (6922) Stock Overview

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, develops, produces, and sells minimally-invasive interventional cryotherapy products in the People's Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. Its products include Bladder Cryoablation System, a cryotherapy device for the treatment of non-muscle-invasive bladder cancer; and the Endoscopic Clip for Anastomosis, an anastomotic device for closure of soft tissue in digestive tract. The company was incorporated in 2013 and is based in Shanghai, the People's Republic of China.